Prognostic significance of hemoglobin concentration in nasopharyngeal carcinoma: Does treatment-induced anemia have negative effect?

In Vivo

Volumn 17, Issue 5, 2003, Pages 483-487

  Altun, Musa ^a   Demiral, Ayse Nur ^b   Meral, Rasim ^a   Kaytan, Esra ^a   Cosar, Rusen ^a   Disci, Rian ^a   Dizdar, Yavuz ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Anemia; Chemotherapy; Nasopharyngeal carcinoma; Prognostic factor; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; HEMOGLOBIN; PLATINUM DERIVATIVE;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; AGE; AGED; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; CRANIAL NERVE TUMOR; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HEMOGLOBIN DETERMINATION; HISTOPATHOLOGY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NASOPHARYNX CARCINOMA; NECK CANCER; PREDICTION; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTOR; SEX DIFFERENCE; TREATMENT OUTCOME;

EID: 0142260924     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Mottram JC and Eidinow A: On the effect of anemia on the reactions of the skin and of tumors to radium exposure. Br J Surg 19: 481-7, 1932.
2. Thomlinson RH and Gray LH: The histological structure of some human lung cancers and the possible implications for radiotherapy. Brit J Cancer 9: 539-49, 1955.
3. Dische S, Saunders MI and Warburton MF: Hemoglobin, radiation, morbidity and survival. Int J Radiat Oncol Biol Phys 12: 1335-7, 1986.
4. Littlewood TJ: The impact of hemoglobin levels on treatment outcomes in patients with cancer. Semin Oncol (Suppl 8), 28(2): 49-53, 2001.
5. Becker A, Stadler P, Lavey RS et al: Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 46: 459-66, 2000.
6. Höckel M and Vaupel P: Biological consequences of tumor hypoxia. Semin Oncol (Suppl 8) 28(2): 36-41, 2001.
7. Zucker S. Anemia in cancer. Cancer Invest 3: 249-60, 1985.
8. Mercadante S, Gebbia V, Marrazzo A et al: Anaemia in cancer: Pathophysiology and treatment. Cancer Treatment Reviews 26: 303-11, 2000.
9. Dische S: Radiotherapy and anaemia - The clinical experience. Radiother Oncol (Suppl 1), 20: 35-40, 1991.
10. Fein DA, Lee WR, Hanlon AL et al: Pretreatment hemoglobin level influences local control and survival of T1-T2 SCC of the glottic larynx. J Clin Oncol 13: 2077-83, 1995.
11. Fazekas JT, Scott C, Marcial V et al: The role of hemoglobin concentration in the outcome of misonidazole-sensitized radiotherapy of head and neck cancers: Based on RTOG trial #79-15. Int J Radiat Oncol Biol Phys 17: 1177-81, 1989.
12. Lammering G, Carl UM, Pape H et al: Change in hemoglobin concentrations in combined RT CT in locally advanced ORL tumors. Strahlenther Onkol 175: 559-62, 1999.
13. Warde P, O'Sullivan B, Bristow RG et al: T1/T2 glottic cancer managed by external beam radiotherapy: The influence of pretreatment hemoglobin on local control. Int J Radiat Oncol Biol Phys 41: 347-53, 1998.
14. Tarnawski R, Skladowski K and Maciejewski B: Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx. Int J Radiat Oncol Biol Phys 38: 1007-11, 1997.
15. Komaki R and Cox JD: Induction or concurrent chemotherapy and radiation therapy for locally advanced NSCLC. In: Van Houtte P, Klastersky J, Rochmans P (eds): Progress and Perspectives in the Treatment of Lung Cancer. Berlin, Germany, Springer-Verlag, 1999, pp 85-94.
16. Furuse K, Fukuoka M, Kawahara M et al.: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer. J Clin Oncol 17: 2692-99, 1999.
17. Curran WJ, Scott C, Langer C et al: Phase III comparison of sequential vs concurrent chemoradiation for patients with unresected stage III non-small cell lung cancer. Initial Report of RTOG 9410 (abstr). Proc Am Soc Clin Oncol 19: 484A, 2000.
18. Pignon JP, Bourhis J, Domenge C et al: On behalf of the MACH-NC Collaborative Group. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. Lancet 355: 949-55, 2000.
19. Al-Sarraf M, LeBlanc M, Giri PG et al: Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099. J Clin Oncol 16(4): 1310-7, 1998.
20. Frommhold H, Guttenberger R and Henke M: The impact of blood hemoglobin content on the outcome of radiotherapy. The Freiburg experience. Strahlenther Onkol 174: 31-34, 1998.
21. Molls M, Stadler P, Becker A et al: Relevance of oxygen in radiation oncology. Mechanisms of action, correlation to low hemoglobin levels. Strahlenther Onkol 174: 13-16, 1998.
22. De Serdio JL, Villar A, Saavedra JA et al: Influence of the necessity of transfusion in anemia on the prognosis of ENT cancer in the protocol with concurrent hyperfractionation of carboplatin and irradiation. An Otorrhinolaringol Ibero Am 25: 233-46, 1998.
23. Fyles A, Milosevic M, Hedley D et al.: Tumor hypoxia has independent predictor impact only in patients with node negative cervix cancer. J Clin Oncol 20(3): 680-7, 2002.
24. Grogan M, Thomas GM, Melamed I et al: The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 86: 1528-36, 1999.
25. Nordsmark M, Overgaard M and Overgaard J: Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 41: 31-9, 1996.
26. Brizel DM, Sibley GS, Prosnitz LR et al: Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 38: 285-9, 1997.
27. Dubray B, Mosseri V, Brunin F et al: Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: A prospective study. Radiology 201: 553-8, 1996.
28. Keane TJ: Hypoxia in radiation therapy - Is it relevant to nasopharyngeal cancer treatment? Presented at UICC Workshop on Nasopharyngeal Cancer: Issues and Challenges, Singapore, February 11-14, 1998.
29. Höckel M and Vaupel P: Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93: 266-76, 2001.
30. Lavey RS and Dempsey WH: Erythropoietin increases hemoglobin in cancer patients during radiation therapy. Int J Radiat Oncol Biol Phys 277: 1147-52, 1993.
31. Vijayakumar S, Roach M, Wara W et al: Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: Preliminary results of a randomized, open-labeled, Phase II trial. Int J Radiat Oncol Biol Phys 26: 721-9, 1993.
32. Wagner W, Hermann R, Hartlapp J et al: Prognostic value of hemoglobin concentrations in patients with advanced head and neck cancer treated with combined radio-chemotherapy and surgery. Strahlenther Onkol 176(2): 73-80, 2000.